Lomudal 20 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

lomudal 20 mg/ ml

stada arzneimittel ag - natriumkromoglikat - Øyedråper, oppløsning - 20 mg/ ml

Lomudal 40 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

lomudal 40 mg/ ml

stada arzneimittel ag - natriumkromoglikat - Øyedråper, oppløsning - 40 mg/ ml

Lomudal Nasal 5.2 mg/ dose Норвешка - Норвешки - Statens legemiddelverk

lomudal nasal 5.2 mg/ dose

sanofi-aventis norge (3) - natriumkromoglikat - nesespray, oppløsning - 5.2 mg/ dose

Lecrolyn sine 40 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

lecrolyn sine 40 mg/ ml

santen oy - natriumkromoglikat - Øyedråper, oppløsning - 40 mg/ ml

Lecrolyn 40 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

lecrolyn 40 mg/ ml

santen oy - natriumkromoglikat - Øyedråper, oppløsning - 40 mg/ ml

Lecrolyn 40 mg/ ml Норвешка - Норвешки - Statens legemiddelverk

lecrolyn 40 mg/ ml

santen oy - natriumkromoglikat - Øyedråper, oppløsning - 40 mg/ ml

Zavicefta Европска Унија - Норвешки - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Zerbaxa Европска Унија - Норвешки - EMA (European Medicines Agency)

zerbaxa

merck sharp & dohme b.v.  - ceftolozane sulfat, tazobactam sodium - bakterielle infeksjoner - antibakterielle midler for systemisk bruk, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Montelukast Teva 4 mg Норвешка - Норвешки - Statens legemiddelverk

montelukast teva 4 mg

teva pharma b.v. (4) - montelukastnatrium - granulat - 4 mg